Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial
Background:
Intermittent preventive treatment of malaria in children (IPTc) is a promising new approach to the control of malaria in areas of seasonal malaria transmission but it is not known if IPTc adds to the protection provided by an insecticide-treated net (ITN).
Methods and Findings:
An individually randomised, double-blind, placebo-controlled trial of seasonal IPTc was conducted in Burkina Faso in children aged 3 to 59 months who were provided with a long-lasting insecticide-treated bednet (LLIN). Three rounds of treatment with sulphadoxine pyrimethamine plus amodiaquine or placebos were given at monthly intervals during the malaria transmission season. Passive surveillance for malaria episodes was established, a cross-sectional survey was conducted at the end of the malaria transmission season, and use of ITNs was monitored during the intervention period. Incidence rates of malaria were compared using a Cox regression model and generalized linear models were fitted to examine the effect of IPTc on the prevalence of malaria infection, anaemia, and on anthropometric indicators. 3,052 children were screened and 3,014 were enrolled in the trial; 1,505 in the control arm and 1,509 in the intervention arm. Similar proportions of children in the two treatment arms were reported to sleep under an LLIN during the intervention period (93%). The incidence of malaria, defined as fever or history of fever with parasitaemia ≥5,000/µl, was 2.88 (95% confidence interval [CI] 2.70–3.06) per child during the intervention period in the control arm versus 0.87 (95% CI 0.78–0.97) in the intervention arm, a protective efficacy (PE) of 70% (95% CI 66%–74%) (p<0.001). There was a 69% (95% CI 6%–90%) reduction in incidence of severe malaria (p = 0.04) and a 46% (95% CI 7%–69%) (p = 0.03) reduction in the incidence of all-cause hospital admissions. IPTc reduced the prevalence of malaria infection at the end of the malaria transmission season by 73% (95% CI 68%–77%) (p<0.001) and that of moderately severe anaemia by 56% (95% CI 36%–70%) (p<0.001). IPTc reduced the risks of wasting (risk ratio [RR] = 0.79; 95% CI 0.65–1.00) (p = 0.05) and of being underweight (RR = 0.84; 95% CI 0.72–0.99) (p = 0.03). Children who received IPTc were 2.8 (95% CI 2.3–3.5) (p<0.001) times more likely to vomit than children who received placebo but no drug-related serious adverse event was recorded.
Conclusions:
IPT of malaria provides substantial protection against malaria in children who sleep under an ITN. There is now strong evidence to support the integration of IPTc into malaria control strategies in areas of seasonal malaria transmission.
Trial Registration: ClinicalTrials.gov NCT00738946
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial. PLoS Med 8(2): e32767. doi:10.1371/journal.pmed.1000408
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000408
Souhrn
Background:
Intermittent preventive treatment of malaria in children (IPTc) is a promising new approach to the control of malaria in areas of seasonal malaria transmission but it is not known if IPTc adds to the protection provided by an insecticide-treated net (ITN).
Methods and Findings:
An individually randomised, double-blind, placebo-controlled trial of seasonal IPTc was conducted in Burkina Faso in children aged 3 to 59 months who were provided with a long-lasting insecticide-treated bednet (LLIN). Three rounds of treatment with sulphadoxine pyrimethamine plus amodiaquine or placebos were given at monthly intervals during the malaria transmission season. Passive surveillance for malaria episodes was established, a cross-sectional survey was conducted at the end of the malaria transmission season, and use of ITNs was monitored during the intervention period. Incidence rates of malaria were compared using a Cox regression model and generalized linear models were fitted to examine the effect of IPTc on the prevalence of malaria infection, anaemia, and on anthropometric indicators. 3,052 children were screened and 3,014 were enrolled in the trial; 1,505 in the control arm and 1,509 in the intervention arm. Similar proportions of children in the two treatment arms were reported to sleep under an LLIN during the intervention period (93%). The incidence of malaria, defined as fever or history of fever with parasitaemia ≥5,000/µl, was 2.88 (95% confidence interval [CI] 2.70–3.06) per child during the intervention period in the control arm versus 0.87 (95% CI 0.78–0.97) in the intervention arm, a protective efficacy (PE) of 70% (95% CI 66%–74%) (p<0.001). There was a 69% (95% CI 6%–90%) reduction in incidence of severe malaria (p = 0.04) and a 46% (95% CI 7%–69%) (p = 0.03) reduction in the incidence of all-cause hospital admissions. IPTc reduced the prevalence of malaria infection at the end of the malaria transmission season by 73% (95% CI 68%–77%) (p<0.001) and that of moderately severe anaemia by 56% (95% CI 36%–70%) (p<0.001). IPTc reduced the risks of wasting (risk ratio [RR] = 0.79; 95% CI 0.65–1.00) (p = 0.05) and of being underweight (RR = 0.84; 95% CI 0.72–0.99) (p = 0.03). Children who received IPTc were 2.8 (95% CI 2.3–3.5) (p<0.001) times more likely to vomit than children who received placebo but no drug-related serious adverse event was recorded.
Conclusions:
IPT of malaria provides substantial protection against malaria in children who sleep under an ITN. There is now strong evidence to support the integration of IPTc into malaria control strategies in areas of seasonal malaria transmission.
Trial Registration: ClinicalTrials.gov NCT00738946
: Please see later in the article for the Editors' Summary
Zdroje
1. WHO 2008 World Malaria report 2008. WHO/HTM/GMP/2008.1. Geneva WHO
2. GreenwoodB
2006 Intermittent preventive treatment–a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health 11 983 991
3. SchellenbergD
MenendezC
KahigwaE
AponteJ
VidalJ
2001 Intermittent treatment for malaria and anaemia control at time of routine vaccination in Tanzanian infants; a randomised, placebo-controlled trial. Lancet 357 1471 1477
4. Institute of Medicine 2008 Available: http://www.iom.edu/Reports/2008/Assessment-of-the-Role-of-Intermittent-Preventive-Treatment-for-Malaria-in-Infants-Letter-Report.aspx. Accessed 10 July 2008.
5. TaylorT
OlolaC
ValimC
AgbenyegaT
KremsnerP
2006 Standardized data collection for multi-centre clinical studies of severe malaria in African children: establishing the SMAC network. Trans R Soc Trop Med Hyg 100 615 622
6. CisséB
SokhnaC
BoulangerD
MiletJ
Bâ elH
2006 Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 367 6596 67
7. DickoA
SagaraI
SissokoMS
GuindoO
DialloAI
2008 Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J 7 123
8. KwekuM
LiuD
AdjuikM
BinkaF
SeiduM
2008 Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One 3 e4000 doi:10.1371/journal.pone.0004000
9. LengelerC
2004 Insecticide-treated bednets and curtains for preventing malaria. Cochrane Database Syst Rev Cd000363
10. DickoA
DialloAI
TembineI
DickoY
DaraN
2011 A randomised, placebo-controlled trial of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine plus amodiaquine in children protected by long lasting insecticide treated nets in Mali. PLoS Med 8 e1000407 doi:10.1371/journal.pmed.1000407
11. ZongoI
DorseyG
RouambaN
DokomajilarC
LankoandeM
2005 Amodiaquine, sulfadoxine-pyrimethamine, combination therapy for the uncomplicated falciparum malaria: randomised controlled trial from Burkina Faso. Am. J Trop Med Hyg 73 826 832
12. ZongoI
DorseyG
RouambaN
TintoH
DokomajilarC
2007 Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet 369 491 498
13. SokhnaC
CisséB
Bâ elH
MilliganP
HallettR
2008 A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One 3 e1471 doi:10.1371/journal.pone.0001471
14. Ilboudo SanogoE
2001 Influence des rideaux imprégnés d'insecticide sur les paramètres entomologiques de la transmission du paludisme en zone rurale au Burkina Faso [PhD dissertation]. Ouagadougou, Burkina Faso Université de Ouagadougou, UFR Science de la Vie et de la Terre 135
15. AbduallahS
AdazuK
MasanjaH
DialloDA
HodgsonA
2007 Patterns of age-specific malaria mortality in children in endemic areas of sub-Saharan Africa. Am J Trop Med and Hyg 77 99 105
16. ChandramohanD
Owusu-AgyeiS
CarneiroI
AwineT
Amponsa-AchianoK
2005 Cluster randomised trial of intermittent preventive treatment of malaria in infants in area of high, seasonal malaria transmission in Ghana. BMJ 331 727 33
17. WHO 2000 Severe falciparum malaria. Trans R Soc Trop Med Hyg 94 S1 S10
18. WHO 2009 Software for assessing growth and development of the world's children. Available: http://www.who.int/childgrowth/software/en/
19. SmithPG
MorrowR
1996 Field trials of health interventions in developing countries: a toolbox. London Macmillan
20. TaylorWR
TerlouwDJ
OllarioPL
WhiteNJ
BrasseurP
2006 Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria. Bull World Health Organ 84 956 964
21. PloweCV
DjimdeA
BouareM
DoumboO
WellemsTE
1995 Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52 565 568
22. DjimdéA
DoumboOK
CorteseJF
KayentaoK
DoumboS
2001 A molecular arker for chloroquine-resistant falciparum malaria. N Engl J Med 344 257 263
23. MarbiahNT
PetersenE
DavidK
MagbityE
LinesJ
1998 A controlled trial of lambda-cyhalothrin-impregnated bed nets and/or dapsone/pyrimethamine for malaria control in Sierra Leone. Am J Trop Med Hyg 58 1 6
24. AlonsoPL
LindsaySW
Armstrong SchellenbergJR
GomezP
HillAG
1993 A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, West Africa. 2. Mortality and morbidity from malaria in the study area. Trans R Soc Trop Med Hyg 87 13 17
25. DanquahI
DietzE
ZangerP
ReitherK
ZinielP
2009 Reduced efficacy of intermittent preventive treatment of malaria in malnourished children. Antimicrob Agents Chemother 53 1753 1759
26. NtabB
CisséB
BoulangerD
SokhnaC
TargettG
2007 Impact of intermittent preventive anti-malarial treatment on the growth and nutritional status of preschool children in rural Senegal (west Africa). Am J Trop Med Hyg 77 411 417
27. GreenwoodBM
GreenwoodAM
BradleyAK
SnowRW
ByassP
1988 Comparison of two strategies for control of malaria within a primary health care programme in the Gambia. Lancet 1 1121 1127
28. CisseB
CairnsM
FayeE
NDiayeO
FayeB
2009 Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS One 4 e7164 doi:10.1371/journal.pone.0007164
29. CairnsM
CisseB
SokhnaC
CamesC
SimondonK
2010 Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children. Antimicrob Agents Chemother 54 1265 1274
30. OrdR
AlexanderN
DunyoS
HallettR
JawaraM
2007 Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J Infect Dis 196 1613 1619
31. KwekuM
WebsterJ
AdjuikM
AbudeyS
GreenwoodB
2009 Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial. PLoS One 4 e7256
32. BojangKA
AkorF
ContehL
WebbEL
BittayeO
2011 Two strategies for the delivery of IPTc in an area of seasonal malaria transmission: a randomized controlled trial. PLoS Med 8 e1000409 doi:10.1371/journal.pmed.1000409
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 2
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Two Strategies for the Delivery of IPTc in an Area of Seasonal Malaria Transmission in The Gambia: A Randomised Controlled Trial
- Violent Deaths of Iraqi Civilians, 2003–2008: Analysis by Perpetrator, Weapon, Time, and Location
- Intermittent Preventive Treatment to Reduce the Burden of Malaria in Children: New Evidence on Integration and Delivery
- Intravaginal Practices, Bacterial Vaginosis, and HIV Infection in Women: Individual Participant Data Meta-analysis